# Phenotype Guided Vasoactive Medication During Kidney Transplantation

> **NCT07633600** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jennifer Cutler** · enrollment: 255 (estimated)

## Conditions studied

- Kidney Transplant
- Fluid Management

## Interventions

- **DRUG:** Phenotype-Guided Vasoactive Management

## Key facts

- **NCT ID:** NCT07633600
- **Lead sponsor:** Jennifer Cutler
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 255 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07633600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07633600, "Phenotype Guided Vasoactive Medication During Kidney Transplantation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07633600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*